GPCR heterodimerization in the reproductive system: Functional regulation and implication for biodiversity

Frontiers in Endocrinology

Volumn 4, Issue AUG, 2013, Pages

  Satake, Honoo ^a   Matsubara, Shin ^a   Aoyama, Masato ^a   Kawada, Tsuyoshi ^a   Sakai, Tsubasa ^a  

^a SUNTORY INSTITUTE FOR BIOORGANIC RESEARCH   (Japan)

Author keywords

Diversity hormones; GPCR; Heterodimer; Reproduction

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ANGIOTENSIN 1 RECEPTOR; BRADYKININ B2 RECEPTOR; CANNABINOID 1 RECEPTOR; DELTA OPIATE RECEPTOR; DOPAMINE 1 RECEPTOR; G PROTEIN COUPLED RECEPTOR; GHRELIN RECEPTOR; GONADORELIN RECEPTOR; HETERODIMER; KAPPA OPIATE RECEPTOR; LUTEINIZING HORMONE RECEPTOR; MELANOCORTIN 3 RECEPTOR; MELATONIN 1 RECEPTOR; MU OPIATE RECEPTOR; OREXIN 1 RECEPTOR; PROSTAGLANDIN E RECEPTOR 1; TACHYKININ RECEPTOR;

ALLOSTERISM; BIODIVERSITY; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CIONA INTESTINALIS; DIMERIZATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE INACTIVATION; GENITAL SYSTEM; HORMONE RELEASE; HUMAN; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; INTERNALIZATION; LIGAND BINDING; NONHUMAN; OOCYTE DEVELOPMENT; OOCYTE MATURATION; OVARY FOLLICLE DEVELOPMENT; OVARY FOLLICLE MATURATION; PHYLOGENY; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION;

EID: 84884256638     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2013.00100     Document Type: Review

References (81)

1. Levoye A, Dam J, Ayoub MA, Guillaume JL, Couturier C, Delagrange P, et al. The orphan GPR50 receptor specifically inhibits MT1 melatonin receptor function through heterodimerization. EMBO J (2006) 25:3012-23. doi:10.1038/sj.emboj.7601193.
2. Pin JP, Neubig R, Bouvier M, Devi L, Filizola M, Javitch JA, et al. International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the recognition and nomenclature of G protein-coupled receptor heteromultimers. Pharmacol Rev (2007) 59:5-13. doi:10.1124/pr.59.1.5.
3. Satake H, Sakai T. Recent advances and perceptions in studies of heterodimerization between G protein-coupled receptors. Protein Pept Lett (2008) 15:300-8. doi:10.2174/092986608783744207.
4. Milligan G. G protein-coupled receptor hetero-dimerization: contribution to pharmacology and function. Br J Pharmacol (2009) 158:5-14. doi:10.1111/j.1476-5381.2009.00169.x.
5. Del Burgo LS, Milligan G. Heterodimerisation of G protein-coupled receptors: implications for drug design and ligand screening. Expert Opin Drug Discov (2010) 5:461-74. doi:10.1517/17460441003720467.
6. Kamal M, Jockers R. Biological significance of GPCR heteromerization in the neuro-endocrine system. Front Endocrinol (Lausanne) (2011) 2:2. doi:10.3389/fendo.2011.00002.
7. Tadagaki K, Jockers R, Kamal M. History and biological significance of GPCR heteromerization in the neuroendocrine system. Neuroendocrinology (2012) 95:223-31. doi:10.1159/000330000.
8. Goupil E, Laporte SA, Hébert TE. Functional selectivity in GPCR signaling: understanding the full spectrum of receptor conformations. Mini Rev Med Chem (2012) 12:817-30. doi:10.2174/138955712800959143
9. Borroto-Escuela DO, Romero-Fernandez W, Garriga P, Ciruela F, Narvaez M, Tarakanov AO, et al. G protein-coupled receptor heterodimerization in the brain. Methods Enzymol (2013) 521:281-94. doi:10.1016/B978-0-12-391862-8.00015-6.
10. Tsutsui K, Ubuka T, Bentley GE, Kriegsfeld LJ. Gonadotropin-inhibitory hormone (GnIH): discovery, progress and prospect. Gen Comp Endocrinol (2012) 177:305-14. doi:10.1016/j.ygcen.2012.02.013.
11. Ubuka T, Son YL, Tobari Y, Tsutsui K. Gonadotropin-inhibitory hormone action in the brain and pituitary. Front Endocrinol (Lausanne) (2012) 3:148. doi:10.3389/fendo.2012.00148.
12. Christensen A, Bentley GE, Cabrera R, Ortega HH, Perfito N, Wu TJ, et al. Hormonal regulation of female reproduction. Horm Metab Res (2012) 44:587-91. doi:10.1055/s-0032-1306301.
13. Franceschini I, Desroziers E. Development and aging of the kisspeptin-GPR54 system in the mammalian brain: what are the impacts on female reproductive function? Front Endocrinol (Lausanne) (2013) 4:22. doi:10.3389/fendo.2013.00022.
14. Okubo K, Nagahama Y. Structural and functional evolution of gonadotropin-releasing hormone in vertebrates. Acta Physiol (Oxf) (2008) 193:3-15. doi:10.1111/j.1748-1716.2008.01832.x.
15. Lindemans M, Janssen T, Beets I, Temmerman L, Meelkop E, Schoofs L. Gonadotropin-releasing hormone and adipokinetic hormone signaling systems share a common evolutionary origin. Front Endocrinol (Lausanne) (2011) 2:16. doi:10.3389/fendo.2011.00016.
16. Sower SA, Decatur WA, Joseph NT, Freamat M. Evolution of vertebrate GnRH receptors from the perspective of a basal vertebrate. Front Endocrinol (Lausanne) (2012) 3:140. doi:10.3389/fendo.2012.00140.
17. Kanda S, Oka Y. Structure, synthesis, and phylogeny of kisspeptin and its receptor. Adv Exp Med Biol (2013) 784:9-26. doi:10.1007/978-1-4614-6199-9_2.
18. Gopurappilly R, Ogawa S, Parhar IS. Functional significance of GnRH and kisspeptin, and their cognate receptors in teleost reproduction. Front Endocrinol (Lausanne) (2013) 4:24. doi:10.3389/fendo.2013.00024.
19. Fanelli F, De Benedetti PG. Update 1 of: computational modeling approaches to structure-function analysis of G protein-coupled receptors. Chem Rev (2011) 111:R438-535. doi:10.1021/cr100437t.
20. Fuxe K, Borroto-Escuela DO, Marcellino D, Romero-Fernandez W, Frankowska M, Guidolin D, et al. GPCR heteromers and their allosteric receptor-receptor interactions. Curr Med Chem (2012) 19:356-63. doi:10.2174/092986712803414259.
21. Milligan G, Smith NJ. Allosteric modulation of heterodimeric G-protein-coupled receptors. Trends Pharmacol Sci (2007) 12:615-20. doi:10.1016/j.tips.2007.11.001.
22. Kaupmann K, Malitschek B, Schuler V, Heid J, Froestl W, Beck P, et al. GABA(B)-receptor subtypes assemble into functional heteromeric complexes. Nature (1998) 396:683-7. doi:10.1038/25360.
23. Duthey B, Caudron S, Perroy J, Bettler B, Fagni L, Pin JP, et al. A single subunit (GB2) is required for G-protein activation by the heterodimeric GABA(B) receptor. J Biol Chem (2002) 277:3236-41. doi:10.1074/jbc.M108900200.
24. Pin JP, Kniazeff J, Liu J, Binet V, Goudet C, Rondard P, et al. Allosteric functioning of dimeric class C G-protein-coupled receptors. FEBS J (2005) 272:2947-55. doi:10.1111/j.1742-4658.2005.04728.x.
25. Nelson G, Hoon MA, Chandrashekar J, Zhang Y, Ryba NJ, Zuker CS. Mammalian sweet taste receptors. Cell (2001) 106:381-90. doi:10.1016/S0092-8674(01)00451-2.
26. Nelson G, Chandrashekar J, Hoon MA, Feng L, Zhao G, Ryba NJ, et al. An amino-acid taste receptor. Nature (2002) 416:199-202. doi:10.1038/nature726.
27. Xu H, Staszewski L, Tang H, Adler E, Zoller M, Li X. Human receptors for sweet and umami taste. Proc Natl Acad Sci USA (2004) 101:14258-63. doi:10.1073/pnas.0404384101.
28. AbdAlla S, Lother H, Quitterer U. AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration. Nature (2000) 407:94-8. doi:10.1038/35024095.
29. AbdAlla S, Lother H, el Massiery A, Quitterer U. Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness. Nat Med (2001) 7:1003-9. doi:10.1038/nm0901-1003.
30. Kieffer BL. Opioids: first lessons from knockout mice. Trends Pharmacol Sci (1999) 20:19-26. doi:10.1016/S0165-6147(98)01279-6.
31. Gomes I, Jordan BA, Gupta A, Trapaidze N, Nagy V, Devi LA. Heterodimerization of mu and delta opioid receptors: a role in opiate synergy. J Neurosci (2000) 20:RC110.
32. Fan T, Varghese G, Nguyen T, Tse R, O'Dowd BF, George SR. A role for the distal carboxyl tails in generating the novel pharmacology and G protein activation profile of mu and delta opioid receptor hetero-oligomers. J Biol Chem (2005) 280:38478-88. doi:10.1074/jbc.M505644200.
33. Waldhoer M, Fong J, Jones RM, Lunzer MM, Sharma SK, Kostenis E, et al. A heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers. Proc Natl Acad Sci USA (2005) 102:9050-5. doi:10.1073/pnas.0501112102.
34. Yekkirala AS, Lunzer MM, McCurdy CR, Powers MD, Kalyuzhny AE, Roerig SC, et al. N-naphthoyl-beta-naltrexamine (NNTA), a highly selective and potent activator of μ/kappa-opioid heteromers. Proc Natl Acad Sci USA (2011) 108:5098-103. doi:10.1073/pnas.1016277108.
35. Ellis J, Pediani JD, Canals M, Milasta S, Milligan G. Orexin-1receptor-cannabinoid CB1 receptor heterodimerization results in both ligand-dependent and -independent coordinated alterations of receptor localization and function. J Biol Chem (2006) 281:38812-24. doi:10.1074/jbc.M602494200.
36. Rediger A, Piechowski CL, Yi CX, Tarnow P, Strotmann R, Grüters A, et al. Mutually opposite signal modulation by hypothalamic heterodimerization of ghrelin and melanocortin-3 receptors. J Biol Chem (2011) 286:39623-31. doi:10.1074/jbc.M111.287607.
37. Rediger A, Piechowski CL, Habegger K, Grüters A, Krude H, Tschöp MH, et al. MC4R dimerization in the paraventricular nucleus and GHSR/MC3R heterodimerization in the arcuate nucleus: is there relevance for body weight regulation? Neuroendocrinology (2012) 9:277-88. doi:10.1159/000334903.
38. Pei L, Li S, Wang M, Diwan M, Anisman H, Fletcher PJ, et al. Uncoupling the dopamine D1-D2 receptor complex exerts antidepressant-like effects. Nat Med (2010) 16:1393-5. doi:10.1038/nm.2263.
39. Rashid AJ, So CH, Kong MM, Furtak T, El-Ghundi M, Cheng R, et al. D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum. Proc Natl Acad Sci USA (2007) 104:654-9. doi:10.1073/pnas.0604049104.
40. He SQ, Zhang ZN, Guan JS, Liu HR, Zhao B, Wang HB, et al. Facilitation of μ-opioid receptor activity by preventing δ-opioid receptor-mediated codegradation. Neuron (2011) 69:120-31. doi:10.1016/j.neuron.2010.12.001.
41. McGuire NL, Bentley GE. Neuropeptides in the gonads: from evolution to pharmacology. Front Pharmacol (2010) 1:114. doi:10.3389/fphar.2010.00114.
42. McGuire NL, Kangas K, Bentley GE. Effects of melatonin on peripheral reproductive function: regulation of testicular GnIH and testosterone. Endocrinology (2011) 152:3461-70. doi:10.1210/en.2011-1053.
43. Levoye A, Dam J, Ayoub MA, Guillaume JL, Jockers R. Do orphan G-protein-coupled receptors have ligand-independent functions? New insights from receptor heterodimers. EMBO Rep (2006) 7:1094-8. doi:10.1038/sj.embor.7400838.
44. Severini C, Improta G, Falconieri-Erspamer G, Salvadori S, Erspamer V. The tachykinin peptide family. Pharmacol Rev (2002) 54:285-322.
45. Almeida TA, Rojo J, Nieto PM, Pinto FM, Hernandez M, Martin JD, et al. Tachykinins and tachykinin receptors: structure and activity relationships. Curr Med Chem (2005) 11:2045-81. doi:10.2174/0929867043364748.
46. Satake H, Kawada T. Overview of the primary structure, tissue-distribution, and functions of tachykinins and their receptors. Curr Drug Targets (2006) 7:963-74. doi:10.2174/138945006778019273.
47. Page NM. Characterization of the gene structures, precursor processing and pharmacology of the endokinin peptides. Vascul Pharmacol (2006) 45:200-8. doi:10.1016/j.vph.2005.08.028.
48. Satake H, Aoyama M, Sekiguchi T, Kawada T. Insight into molecular and functional diversity of tachykinins and their receptors. Protein Pept Lett (2013) 20:615-27. doi:10.2174/0929866511320060002.
49. Satake H, Ogasawara M, Kawada T, Masuda K, Aoyama M, Minakata H, et al. Tachykinin and tachykinin receptor of an ascidian, Ciona intestinalis: evolutionary origin of the vertebrate tachykinin family. J Biol Chem (2004) 279:53798-805. doi:10.1074/jbc.M408161200.
50. Satake H, Kawada T, Aoyama M, Sekiguchi T, Sakai T. Ascidians: new model orgnanisms for reproductive endocrinology. In: Aimaretti G, Marzullo P, Prodam F editors. Update on Mechanisms of Hormone Action - Focus on Metabolism, Growth and Reproductions. Vienna: IN-TECH (2011). p. 313-36.
51. Pennefather JN, Patak E, Ziccone S, Lilley A, Pinto FM, Page NM, et al. Regulation of the stimulant actions of neurokinin a and human hemokinin-1 on the human uterus: a comparison with histamine. Biol Reprod (2006) 75:334-41. doi:10.1095/biolreprod.106.051508.
52. Ravina CG, Seda M, Pinto FM, Orea A, Fernandez-Sanchez M, Pintado CO, et al. A role for tachykinins in the regulation of human sperm motility. Hum Reprod (2007) 22:1617-25. doi:10.1093/humrep/dem069.
53. Patak E, Pennefather JN, Gozali M, Candenas ML, Kerr K, Exintaris B, et al. Functional characterisation of hemokinin-1 in mouse uterus. Eur J Pharmacol (2008) 601:148-53. doi:10.1016/j.ejphar.2008.10.036.
54. Pinto FM, Ravina CG, Subiran N, Cejudo-Román A, Fernández-Sánchez M, Irazusta J, et al. Autocrine regulation of human sperm motility by tachykinins. Reprod Biol Endocrinol (2010) 8:104. doi:10.1186/1477-7827-8-104.
55. Aoyama M, Kawada T, Fujie M, Hotta K, Sakai T, Sekiguchi T, et al. A novel biological role of tachykinins as an up-regulator of oocyte growth: identification of an evolutionary origin of tachykininergic functions in the ovary of the ascidian, Ciona intestinalis. Endocrinology (2008) 149:4346-56. doi:10.1210/en.2008-0323.
56. Aoyama M, Kawada T, Satake H. Localization and enzymatic activity profiles of the proteases responsible for tachykinin-directed oocyte growth in the protochordate, Ciona intestinalis. Peptides (2012) 34:186-92. doi:10.1016/j.peptides.2011.07.019.
57. Kawada T, Ogasawara M, Sekiguchi T, Aoyama M, Hotta K, Oka K, et al. Peptidomic analysis of the central nervous system of the protochordate, Ciona intestinalis: homologs and prototypes of vertebrate peptides and novel peptides. Endocrinology (2011) 152:2416-27. doi:10.1210/en.2010-1348.
58. Topaloglu AK, Reimann F, Guclu M, Yalin AS, Kotan LD, Porter KM, et al. TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for Neurokinin B in the central control of reproduction. Nat Genet (2009) 41:354-8. doi:10.1038/ng.306.
59. Rance NE, Krajewski SJ, Smith MA, Cholanian M, Dacks PA. Neurokinin B and the hypothalamic regulation of reproduction. Brain Res (2010) 1364:116-28. doi:10.1016/j.brainres.2010.08.059.
60. Lasaga M, Debeljuk L. Tachykinins and the hypothalamo-pituitary-gonadal axis: an update. Peptides (2011) 32:1972-8. doi:10.1016/j.peptides.2011.07.009.
61. Molnár CS, Vida B, Sipos MT, Ciofi P, Borsay Bá, Rácz K, et al. Morphological evidence for enhanced kisspeptin and neurokinin B signaling in the infundibular nucleus of the aging man. Endocrinology (2012) 153:5428-39. doi:10.1210/en.2012-1739.
62. Grachev P, Li XF, Kinsey-Jones JS, di Domenico AL, Millar RP, Lightman SL, et al. Suppression of the GnRH pulse generator by neurokinin B involves a κ-opioid receptor-dependent mechanism. Endocrinology (2012) 153:4894-904. doi:10.1210/en.2012-1574.
63. Hrabovszky E, Sipos MT, Molnár CS, Ciofi P, Borsay Bá, Gergely P, et al. Low degree of overlap between kisspeptin, neurokinin B, and dynorphin immunoreactivities in the infundibular nucleus of young male human subjects challenges the KNDy neuron concept. Endocrinology (2012) 153:4978-89. doi:10.1210/en.2012-1545.
64. Gill JC, Navarro VM, Kwong C, Noel SD, Martin C, Xu S, et al. Increased neurokinin B (Tac2) expression in the mouse arcuate nucleus is an early marker of pubertal onset with differential sensitivity to sex steroid-negative feedback than Kiss1. Endocrinology (2012) 153:4883-93. doi:10.1210/en.2012-1529.
65. Ruiz-Pino F, Navarro VM, Bentsen AH, Garcia-Galiano D, Sanchez-Garrido MA, Ciofi P, et al. Neurokinin B and the control of the gonadotropic axis in the rat: developmental changes, sexual dimorphism, and regulation by gonadal steroids. Endocrinology (2012) 153:4818-29. doi:10.1210/en.2012-1287.
66. Pfeiffer M, Kirscht S, Stumm R, Koch T, Wu D, Laugsch M, et al. Heterodimerization of substance P and mu-opioid receptors regulates receptor trafficking and resensitization. J Biol Chem (2003) 278:51630-7. doi:10.1074/jbc.M307095200.
67. Kah O, Lethimonier C, Somoza G, Guilgur LG, Vaillant C, Lareyre JJ. GnRH and GnRH receptors in metazoa: a historical, comparative, and evolutive perspective. Gen Comp Endocrinol (2007) 153:346-64. doi:10.1016/j.ygcen.2007.01.030.
68. Millar RP, Pawson AJ, Morgan K, Rissman EF, Lu ZL. Diversity of actions of GnRHs mediated by ligand-induced selective signaling. Front Neuroendocrinol (2008) 29:17-35. doi:10.1016/j.yfrne.2007.06.002.
69. Adams BA, Tello J, Erchegyi J, Warby C, Hong DJ, Akinsanya KO, et al. Six novel gonadotropin-releasing hormones are encoded as triplets on each of two genes in the protochordate, Ciona intestinalis. Endocrinology (2003) 144:1907-19. doi:10.1210/en.2002-0216.
70. Tello JA, River J, Sherwood NM. Tunicate gonadotropin-releasing hormone (GnRH) peptides selectively activate Ciona intestinalis GnRH receptors and the green monkey type II GnRH receptor. Endocrinology (2005) 146:4061-73. doi:10.1210/en.2004-1558.
71. Kawada T, Aoyama M, Okada I, Sakai T, Sekiguchi T, Ogasawara M, et al. A novel inhibitory gonadotropin-releasing hormone-related neuropeptide in the ascidian, Ciona intestinalis. Peptides (2009) 30:2200-5. doi:10.1016/j.peptides.2009.08.014.
72. Kusakabe T, Mishima S, Shimada I, Kitajima Y, Tsuda M. Structure, expression, and cluster organization of genes encoding gonadotropin-releasing hormone receptors found in the neural complex of the ascidian Ciona intestinalis. Gene (2003) 322:77-84. doi:10.1016/j.gene.2003.08.013.
73. Sakai T, Aoyama M, Kusakabe T, Tsuda M, Satake H. Functional diversity of signaling pathways through G protein-coupled receptor heterodimerization with a species-specific orphan receptor subtype. Mol Biol Evol (2010) 27:1097-106. doi:10.1093/molbev/msp319.
74. Sakai T, Aoyama M, Kawada T, Kusakabe T, Tsuda M, Satake H. Evidence for differential regulation of GnRH signaling via heterodimerization among GnRH receptor paralogs in the protochordate, Ciona intestinalis. Endocrinology (2012) 153:1841-9. doi:10.1210/en.2011-1668.
75. Kusakabe TG, Sakai T, Aoyama M, Kitajima Y, Miyamoto Y, Takigawa T, et al. A conserved non-reproductive GnRH system in chordates. PLoS ONE (2012) 7:e41955. doi:10.1371/journal.pone.0041955.
76. Rivero-Muller A, Chou YY, Ji I, Lajic S, Hanyaloglu AC, Jonas K, et al. Rescue of defective G protein-coupled receptor function in vivo by intermolecular cooperation. Proc Natl Acad Sci USA (2010) 107:2319-24. doi:10.1073/pnas.0906695106.
77. Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev (1999) 79:1193-226.
78. Matsui M, Miyamoto A. Evaluation of ovarian blood flow by colour Doppler ultrasound: practical use for reproductive management in the cow. Vet J (2009) 181:232-40. doi:10.1016/j.tvjl.2008.02.027.
79. Fujimori C, Ogiwara K, Hagiwara A, Rajapakse S, Kimura A, Takahashi T. Expression of cyclooxygenase-2 and prostaglandin receptor EP4b mRNA in the ovary of the medaka fish, Oryzias latipes: possible involvement in ovulation. Mol Cell Endocrinol (2011) 332:67-77. doi:10.1016/j.mce.2010.09.015.
80. Takahashi T, Fujimori C, Hagiwara A, Ogiwara K. Recent advances in the understanding of teleost medaka ovulation: the roles of proteases and prostaglandins. Zool Sci (2013) 30:239-47. doi:10.2108/zsj.30.239.
81. McGraw DW, Mihlbachler KA, Schwarb MR, Rahman FF, Small KM, Almoosa KF, et al. Airway smooth muscle prostaglandin-EP1 receptors directly modulate beta2-adrenergic receptors within a unique heterodimeric complex. J Clin Invest (2006) 116:1400-9. doi:10.1172/JCI25840.